Protocol for a Multicentre Prehospital Randomised Controlled Trial Investigating Tranexamic Acid in Severe Trauma: the PATCH-Trauma Trial

Overview

Journal BMJ Open

Specialty General Medicine

Date 2021 Mar 16

PMID 33722875

Citations 7

Authors

Biswadev Mitra

Stephen Bernard

Dashiell Gantner

Brian Burns

Michael C Reade

Lynnette Murray

Tony Trapani

Veronica Pitt

Colin McArthur

Andrew Forbes

Marc Maegele

Russell L Gruen

Affiliations

Soon will be listed here.

Abstract

Introduction: Haemorrhage causes most preventable prehospital trauma deaths and about a third of in-hospital trauma deaths. Tranexamic acid (TXA), administered soon after hospital arrival in certain trauma systems, is an effective therapy in preventing or managing acute traumatic coagulopathy. However, delayed administration of TXA appears to be ineffective or harmful. The effectiveness of prehospital TXA, incidence of thrombotic complications, benefit versus risk in advanced trauma systems and the mechanism of benefit remain uncertain.

Methods And Analysis: The Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH-Trauma study) is comparing TXA, initiated prehospital and continued in hospital over 8 hours, with placebo in patients with severe trauma at risk of acute traumatic coagulopathy. We present the trial protocol and an overview of the statistical analysis plan. There will be 1316 patients recruited by prehospital clinicians in Australia, New Zealand and Germany. The primary outcome will be the eight-level Glasgow Outcome Scale Extended (GOSE) at 6 months after injury, dichotomised to favourable (GOSE 5-8) and unfavourable (GOSE 1-4) outcomes, analysed using an intention-to-treat (ITT) approach. Secondary outcomes will include mortality at hospital discharge and at 6 months, blood product usage, quality of life and the incidence of predefined adverse events.

Ethics And Dissemination: The study was approved by The Alfred Hospital Research and Ethics Committee in Victoria and also approved in New South Wales, Queensland, South Australia, Tasmania and the Northern Territory. In New Zealand, Northern A Health and Disability Ethics Committee provided approval. In Germany, Witten/Herdecke University has provided ethics approval. The PATCH-Trauma study aims to provide definitive evidence of the effectiveness of prehospital TXA, when used in conjunction with current advanced trauma care, in improving outcomes after severe injury.

Trial Registration Number: NCT02187120.

Citing Articles

Does Tranexamic Acid Administration Increase the Risk of Thromboembolism?.

Al Babtain I, Alhadlaq K, Aljaafri Z, Alhaqbani A, Al-Mutairi A, Alzamel H Cureus. 2024; 16(9):e69334.

PMID: 39398727 PMC: 11471124. DOI: 10.7759/cureus.69334.

Validation of necrotising infection clinical composite endpoint in a retrospective cohort of patients with necrotising soft tissue infections.

Bion V, Jape D, Niesen R, Angliss M, Bruscino-Raiola F, Mitra B Diving Hyperb Med. 2024; 54(3):155-161.

PMID: 39288918 PMC: 11659063. DOI: 10.28920/dhm54.3.155-161.

Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach.

Liu Z, McCutcheon F, Ho H, Chia J, Xiao Y, Tippett I Res Pract Thromb Haemost. 2023; 7(6):102166.

PMID: 37694270 PMC: 10483050. DOI: 10.1016/j.rpth.2023.102166.

Tranexamic acid - a promising hemostatic agent with limitations: a narrative review.

Kim D, Cho S, Jung K Korean J Anesthesiol. 2023; 77(4):411-422.

PMID: 37599607 PMC: 11294883. DOI: 10.4097/kja.23530.

Pre-hospital freeze-dried plasma for critical bleeding after trauma: A pilot randomized controlled trial.

Mitra B, Meadley B, Bernard S, Maegele M, Gruen R, Bradley O Acad Emerg Med. 2023; 30(10):1013-1019.

PMID: 37103482 PMC: 10946458. DOI: 10.1111/acem.14745.

References

Haagsma J, Graetz N, Bolliger I, Naghavi M, Higashi H, Mullany E . The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev. 2015; 22(1):3-18. PMC: 4752630. DOI: 10.1136/injuryprev-2015-041616. View

Reade M, Pitt V, Gruen R . Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2013; 40(2):160-1. DOI: 10.1097/SHK.0b013e31829ab240. View

Roberts I, Edwards P, Prieto D, Joshi M, Mahmood A, Ker K . Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms. Trials. 2017; 18(1):48. PMC: 5282847. DOI: 10.1186/s13063-016-1750-1. View

Morrison J, Dubose J, Rasmussen T, Midwinter M . Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2011; 147(2):113-9. DOI: 10.1001/archsurg.2011.287. View

El-Menyar A, Sathian B, Asim M, Latifi R, Al-Thani H . Efficacy of prehospital administration of tranexamic acid in trauma patients: A meta-analysis of the randomized controlled trials. Am J Emerg Med. 2018; 36(6):1079-1087. DOI: 10.1016/j.ajem.2018.03.033. View

Lecker I, Wang D, Whissell P, Avramescu S, Mazer C, Orser B . Tranexamic acid-associated seizures: Causes and treatment. Ann Neurol. 2015; 79(1):18-26. PMC: 4738442. DOI: 10.1002/ana.24558. View

Brown J, Neal M, Guyette F, Peitzman A, Billiar T, Zuckerbraun B . Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: Addressing the Knowledge Gaps. Prehosp Emerg Care. 2014; 19(1):79-86. PMC: 4623322. DOI: 10.3109/10903127.2014.936635. View

Pusateri A, Weiskopf R, Bebarta V, Butler F, Cestero R, Chaudry I . Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2012; 39(2):121-6. DOI: 10.1097/SHK.0b013e318280409a. View

Mitra B, Cameron P, Mori A, Fitzgerald M . Acute coagulopathy and early deaths post major trauma. Injury. 2010; 43(1):22-5. DOI: 10.1016/j.injury.2010.10.015. View

10.

Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y . Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32. DOI: 10.1016/S0140-6736(10)60835-5. View

11.

Cole E, Davenport R, Willett K, Brohi K . Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study. Ann Surg. 2014; 261(2):390-4. DOI: 10.1097/SLA.0000000000000717. View

12.

Cook D, Lauzier F, Rocha M, Sayles M, Finfer S . Serious adverse events in academic critical care research. CMAJ. 2008; 178(9):1181-4. PMC: 2292790. DOI: 10.1503/cmaj.071366. View

13.

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y . The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377(9771):1096-101, 1101.e1-2. DOI: 10.1016/S0140-6736(11)60278-X. View

14.

Dinh M, Cornwall K, Bein K, Gabbe B, Tomes B, Ivers R . Health status and return to work in trauma patients at 3 and 6 months post-discharge: an Australian major trauma centre study. Eur J Trauma Emerg Surg. 2015; 42(4):483-490. DOI: 10.1007/s00068-015-0558-0. View

15.

Draxler D, Medcalf R . Fibrinolysis and tranexamic acid: mechanistic principles. ANZ J Surg. 2020; 90(4):410-411. DOI: 10.1111/ans.15541. View

16.

MacLeod J, Winkler A, McCoy C, Hillyer C, Shaz B . Early trauma induced coagulopathy (ETIC): prevalence across the injury spectrum. Injury. 2014; 45(5):910-5. DOI: 10.1016/j.injury.2013.11.004. View

17.

Gruen R, Jacobs I, Reade M . Tranexamic acid and trauma. Med J Aust. 2014; 200(5):255. DOI: 10.5694/mja13.00023. View

18.

Mitra B, Cameron P, Mori A, Maini A, Fitzgerald M, Paul E . Early prediction of acute traumatic coagulopathy. Resuscitation. 2011; 82(9):1208-13. DOI: 10.1016/j.resuscitation.2011.04.007. View

19.

Nielsen K, Mock C, Joshipura M, Rubiano A, Zakariah A, Rivara F . Assessment of the status of prehospital care in 13 low- and middle-income countries. Prehosp Emerg Care. 2012; 16(3):381-9. PMC: 3360803. DOI: 10.3109/10903127.2012.664245. View

20.

Moher D, Hopewell S, Schulz K, Montori V, Gotzsche P, Devereaux P . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c869. PMC: 2844943. DOI: 10.1136/bmj.c869. View